GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE platform, today announced Dr. Jeffrey Miller's mini-oral presentation at the European Society for Medical Oncology (ESMO) Congress 2021.
The total amount of federal public education stimulus funds that California received from Congress during the COVID-19 pandemic is $21.1 billion, according to a tally from the National Conference of State Legislatures (NCSL).
There were no new teachers in Santa Monica who signed the pledge in week ending Sept. 25, according to an online pledge from the Zinn Education Project.
There were no new teachers in Culver City who signed the pledge in week ending Sept. 25, according to an online pledge from the Zinn Education Project.
There were no new teachers in Santa Monica who signed the pledge in week ending Sep. 18, according to an online pledge from the Zinn Education Project.
There were no new teachers in Beverly Hills who signed the pledge in week ending Sept. 25, according to an online pledge from the Zinn Education Project.
There were no new teachers in Beverly Hills who signed the pledge in week ending Sep. 18, according to an online pledge from the Zinn Education Project.
GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE® protein biologic technology platform, today, announces the advancement of GTB-3650 into IND-enabling studies, with which it plans to supplant the ongoing Phase 1 program with GTB-3550.
The Los Angeles County Department of Public Health (LACDPH) will issue a new Health Officer Order that requires customers to show proof of their COVID-19 vaccination prior to entering indoor bars, wineries, breweries, nightclubs and lounges.
GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager, TriKE protein biologic technology platform, today announced that Jeffrey Miller, MD, University of Minnesota Medical School, Professor of Medicine, Division of Hematology, Oncology and Transportation will present a mini-oral presentation at the European Society for Medical Oncology (ESMO) Congress 2021 to be held virtually September 16-21.
The Los Angeles County District Attorney’s Office has filed charges against Jarvis Mathias Newman AKA Marquis Perkings, a 26-year-old male, for his involvement in two separate incidents in Santa Monica.
On Sept. 17, Dauer Partnership Ltd. purchased a five bedroom, seven bathroom home at 661 Doheny Road, Beverly Hills from Available Not for $17,700,000.